ETLI.DE vs. 2B70.DE

Last updated Apr 2, 2026

Compare and contrast key facts about L&G Pharma Breakthrough UCITS ETF (ETLI.DE) and iShares Nasdaq US Biotechnology UCITS ETF (2B70.DE).

ETLI.DE and 2B70.DE are both exchange-traded funds (ETFs), meaning they are traded on stock exchanges and can be bought and sold throughout the day. ETLI.DE is a passively managed fund by Legal & General that tracks the performance of the Solactive Pharma Breakthrough Value. It was launched on Jan 18, 2018. 2B70.DE is a passively managed fund by iShares that tracks the performance of the Nasdaq Biotechnology. It was launched on Oct 19, 2017. Both ETLI.DE and 2B70.DE are passive ETFs, meaning that they are not actively managed but aim to replicate the performance of the underlying index as closely as possible.

Performance

ETLI.DE vs. 2B70.DE - Performance Comparison

The chart below illustrates the hypothetical performance of a €10,000 investment in L&G Pharma Breakthrough UCITS ETF (ETLI.DE) and iShares Nasdaq US Biotechnology UCITS ETF (2B70.DE). The values are adjusted to include any dividend payments, if applicable.

ETLI.DE vs. 2B70.DE - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018
ETLI.DE L&G Pharma Breakthrough UCITS ETF	1.80%	22.23%	0.42%	-12.64%	-2.91%	4.98%	15.37%	17.53%	-4.78%
2B70.DE iShares Nasdaq US Biotechnology UCITS ETF	3.64%	18.62%	4.60%	2.56%	-6.29%	7.59%	14.52%	30.18%	-5.37%

Returns By Period

In the year-to-date period, ETLI.DE achieves a 1.80% return, which is significantly lower than 2B70.DE's 3.64% return.

ETLI.DE

• 1D: 2.16%
• 1M: 2.73%
• YTD: 1.80%
• 6M: 7.95%
• 1Y: 22.40%
• 3Y*: 4.82%
• 5Y*: 2.36%
• 10Y*: —

2B70.DE

• 1D: 1.60%
• 1M: -0.58%
• YTD: 3.64%
• 6M: 18.58%
• 1Y: 29.69%
• 3Y*: 10.78%
• 5Y*: 4.95%
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

ETLI.DE vs. 2B70.DE - Expense Ratio Comparison

ETLI.DE has a 0.49% expense ratio, which is higher than 2B70.DE's 0.35% expense ratio.

ETLI.DE

L&G Pharma Breakthrough UCITS ETF

2B70.DE

iShares Nasdaq US Biotechnology UCITS ETF

Return for Risk

ETLI.DE vs. 2B70.DE — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

ETLI.DE

ETLI.DE Risk / Return Rank: 58
ETLI.DE Sharpe Ratio Rank: 56
ETLI.DE Sortino Ratio Rank: 54
ETLI.DE Omega Ratio Rank: 49
ETLI.DE Calmar Ratio Rank: 69
ETLI.DE Martin Ratio Rank: 63

2B70.DE

2B70.DE Risk / Return Rank: 74
2B70.DE Sharpe Ratio Rank: 71
2B70.DE Sortino Ratio Rank: 70
2B70.DE Omega Ratio Rank: 63
2B70.DE Calmar Ratio Rank: 82
2B70.DE Martin Ratio Rank: 86

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

ETLI.DE vs. 2B70.DE - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for L&G Pharma Breakthrough UCITS ETF (ETLI.DE) and iShares Nasdaq US Biotechnology UCITS ETF (2B70.DE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	ETLI.DE	2B70.DE	Difference
Sharpe ratio Return per unit of total volatility	1.07	1.31	-0.25
Sortino ratio Return per unit of downside risk	1.51	1.83	-0.32
Omega ratio Gain probability vs. loss probability	1.20	1.24	-0.04
Calmar ratio Return relative to maximum drawdown	2.01	2.49	-0.48
Martin ratio Return relative to average drawdown	7.18	10.78	-3.59
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

ETLI.DE vs. 2B70.DE - Sharpe Ratio Comparison

The current ETLI.DE Sharpe Ratio is 1.07, which is comparable to the 2B70.DE Sharpe Ratio of 1.31. The chart below compares the historical Sharpe Ratios of ETLI.DE and 2B70.DE, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Sharpe Ratios by Period

	ETLI.DE	2B70.DE	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	1.07	1.31	-0.25
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	0.14	0.24	-0.10
Sharpe Ratio (All Time) Calculated using the full available price history	0.25	0.36	-0.11

Correlation

The correlation between ETLI.DE and 2B70.DE is 0.81, which is considered to be high. That indicates a strong positive relationship between their price movements. Having highly-correlated positions in a portfolio may signal a lack of diversification, potentially leading to increased risk during market downturns.

Dividends

ETLI.DE vs. 2B70.DE - Dividend Comparison

Neither ETLI.DE nor 2B70.DE has paid dividends to shareholders.

Tickers have no history of dividend payments

Drawdowns

ETLI.DE vs. 2B70.DE - Drawdown Comparison

The maximum ETLI.DE drawdown since its inception was -30.83%, roughly equal to the maximum 2B70.DE drawdown of -30.87%. Use the drawdown chart below to compare losses from any high point for ETLI.DE and 2B70.DE.

Drawdown Indicators

	ETLI.DE	2B70.DE	Difference
Max Drawdown Largest peak-to-trough decline	-30.83%	-30.87%	+0.04%
Max Drawdown (1Y) Largest decline over 1 year	-14.80%	-15.56%	+0.76%
Max Drawdown (5Y) Largest decline over 5 years	-30.83%	-30.87%	+0.04%
Current Drawdown Current decline from peak	-1.36%	-1.07%	-0.29%
Average Drawdown Average peak-to-trough decline	-10.38%	-10.17%	-0.21%
Ulcer Index Depth and duration of drawdowns from previous peaks	3.40%	2.93%	+0.47%

Volatility

ETLI.DE vs. 2B70.DE - Volatility Comparison

L&G Pharma Breakthrough UCITS ETF (ETLI.DE) has a higher volatility of 7.39% compared to iShares Nasdaq US Biotechnology UCITS ETF (2B70.DE) at 6.80%. This indicates that ETLI.DE's price experiences larger fluctuations and is considered to be riskier than 2B70.DE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	ETLI.DE	2B70.DE	Difference
Volatility (1M) Calculated over the trailing 1-month period	7.39%	6.80%	+0.59%
Volatility (6M) Calculated over the trailing 6-month period	14.09%	14.03%	+0.06%
Volatility (1Y) Calculated over the trailing 1-year period	20.90%	22.48%	-1.58%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	17.01%	20.46%	-3.45%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	18.87%	21.78%	-2.91%